Internet Explorer does not cooperate well with this platform. Please see below for options that work with APNA eLearning Center programs.* 

3045-23: Goodbye X-Waiver: Good News for PMHNPs and for the Treatment of People with Opioid Use Disorder

This interactive presentation discusses the 2023 legislation eliminating the DEA X-Waiver buprenorphine prescription requirement and the implications for clinical practice. Buprenorphine prescribing tips and practical pearls are discussed to increase the confidence and knowledge of PMHNPs now eligible to prescribe this life saving medication.

Presenters:  Kayla Cross, PMHNP-BC, ARNP; Jeffery Ramirez, PhD, PMHNP-BC, CARN-AP

Disclosures:  The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will not be discussed during this presentation.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Describe a buprenorphine induction plan for persons with an opioid use disorder diagnosis.

Keywords:  OUD, Fentanyl, MSUD

Nursing Continuing Professional Development:
0.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Price: Free through September 29, 2024 

Grant Statement:

Funding for this initiative was made possible (in part) by grant no. 1H79TI0855888-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Access to this course will end:  November 30, 2025

*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.